Genomma Financial Statements From 2010 to 2025
Genomma Lab financial statements provide useful quarterly and yearly information to potential Genomma Lab Internacional investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Genomma Lab financial statements helps investors assess Genomma Lab's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Genomma Lab's valuation are summarized below:Genomma Lab Internacional does not presently have any fundamental trends for analysis.
This module can also supplement various Genomma Lab Technical models . Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Check Genomma Lab financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Genomma Lab's main balance sheet or income statement drivers, such as , as well as many indicators such as . Genomma financial statements analysis is a perfect complement when working with Genomma Lab Valuation or Volatility modules.
Genomma |
Genomma Lab Internacional Company Profit Margin Analysis
Genomma Lab's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Genomma Lab Profit Margin | 0.08 % |
Most of Genomma Lab's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Genomma Lab Internacional is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
CompetitionBased on the latest financial disclosure, Genomma Lab Internacional has a Profit Margin of 0.081%. This is 100.72% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The profit margin for all United States stocks is 106.38% lower than that of the firm.
Genomma Lab Internacional Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genomma Lab's current stock value. Our valuation model uses many indicators to compare Genomma Lab value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genomma Lab competition to find correlations between indicators driving Genomma Lab's intrinsic value. More Info.Genomma Lab Internacional is rated below average in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about 0.73 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genomma Lab Internacional is roughly 1.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genomma Lab's earnings, one of the primary drivers of an investment's value.Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in Genomma Pink Sheet
If you are still planning to invest in Genomma Lab Internacional check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genomma Lab's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |